Filing Details
- Accession Number:
- 0001171843-16-010658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-14 17:00:39
- Reporting Period:
- 2016-06-10
- Filing Date:
- 2016-06-14
- Accepted Time:
- 2016-06-14 17:00:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722830 | Immunomedics Inc | IMMU | In Vitro & In Vivo Diagnostic Substances (2835) | 611009366 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202016 | L Cynthia Goldenberg | C/O Immunomedics, Inc. 300 The American Road Morris Plains NJ 07950 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-10 | 11,326 | $2.63 | 650,396 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-10 | 11,326 | $3.07 | 639,070 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-06-10 | 81,990 | $2.50 | 5,317,452 | No | 4 | M | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-06-10 | 10,050 | $2.63 | 5,327,502 | No | 4 | M | Indirect | See footnote |
| Common Stock | Disposition | 2016-06-10 | 92,040 | $3.05 | 5,235,462 | No | 4 | S | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-06-13 | 128,674 | $2.63 | 767,744 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-13 | 128,674 | $3.02 | 639,070 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-06-13 | 139,950 | $2.63 | 5,375,412 | No | 4 | M | Indirect | See footnote |
| Common Stock | Disposition | 2016-06-13 | 139,950 | $3.02 | 5,235,462 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | See footnote |
| No | 4 | M | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2016-06-10 | 11,326 | $0.00 | 11,326 | $2.63 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2016-06-10 | 81,990 | $0.00 | 81,990 | $2.50 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2016-06-10 | 10,050 | $0.00 | 10,050 | $2.63 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2016-06-13 | 128,674 | $0.00 | 128,674 | $2.63 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2016-06-13 | 139,950 | $0.00 | 139,950 | $2.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 128,674 | 2016-06-14 | No | 4 | M | Direct | |
| 0 | 2016-06-10 | No | 4 | M | Indirect | |
| 139,950 | 2016-06-14 | No | 4 | M | Indirect | |
| 0 | 2016-06-14 | No | 4 | M | Direct | |
| 0 | 2016-06-14 | No | 4 | M | Indirect |
Footnotes
- Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Patent Officer and Chairman of the Board of Directors.
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.07 to $3.08.
- The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
- The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.04 to $3.085.
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.00 to $3.12.
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $2.96 to $3.12.
- These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year.
- These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
- The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.
- The reporting person's spouse was granted these stock options pursuant to the Issuer's 2002 Stock Incentive Plan.
Billionaire Hedge Funds
